Teva selling U.S. veterinary drug unit to Bayer

Germany's Bayer has agreed to buy Teva Pharmaceutical Industries' U.S. animal health operations for up to $145 million to bolster its veterinary drug business.

By Yoram Gabison | 01:26 19.09.12 |

Text size

this story is by

Yoram Gabison

Germany's Bayer has agreed to buy Teva Pharmaceutical Industries' U.S. animal health operations for up to $145 million to bolster its veterinary drug business.

The full text is available for subscribers & registered users.

Click here to subscribe ($1 for the first 4 weeks)
register (free access for 10 stories a month) or

comments

thank you

Your talkback has been submitted successfully.
If selected for publication, it will appear as soon as possible on Haaretz.com.

Reply again

Haaretz Select

Breaking Israel's holy trinity: Settlers, religious and the wealthy

Is there any hope for reviving the radical spirit of the early Zionists?

By Eva Illouz | Magazine

The Pulitzer Prize winning operation run out of an apartment in Tel Aviv

By Omer Shubert | Magazine

Rewriting history (again): What stance on Arabs will Israel's new education minister take?

By Or Kashti | Weekend

Israel can act fast on gun control, so why not on peace talks?

By Ilene Prusher | Jerusalem Vivendi | 6

From treating Shahs to revolutionizing Israeli medicine: The enigmatic life of Professor Moshe Many

Prof. Moshe Many flourished in private medicine but now believes it should be abolished. Even stranger, he served as Israel's go-between to key Middle Eastern figures, including Saudi King Fahd. Looking back at a remarkable life.

By Yoram Gabison | Weekend | 4

Footloose: Former Batsheva dancer breaks her silence

By Elad Samorzik | Magazine

Why Israelis refuse to admit they are poor

By Yossi Klein | Weekend

At Israel's Ashdod port, a tale of mind over body

By Alon Idan | Weekend

Business

Israeli electric car venture may have reached the end of the road

By Yoram Gabison | 10:40 PM

Tech roundup / Angels in Tel Aviv flock to OurCrowd

By Ruth Schuster | 01:21 PM

Report: Google may outbid Facebook for Israeli startup Waze

By Reuters | 10:13 AM

IDB bondholders taking control, Dankner may lose job

By Assa Sasson, Michael Rochvarger | 08:28 AM

Facebook

Activity
Recommendations

Teva selling U.S. veterinary drug unit to Bayer

Germany's Bayer has agreed to buy Teva Pharmaceutical Industries' U.S. animal health operations for up to $145 million to bolster its veterinary drug business.

REPLY TO THIS TALKBACK